SOSV logo

SOSV

North America, New Jersey, United States, Princeton

Description

SOSV is a prominent deep tech venture capital firm headquartered in Princeton, United States, renowned for its unique accelerator model that invests from a startup's inception. With over $1.5 billion in assets under management, SOSV has established itself as a significant player in the early-stage venture ecosystem, particularly for companies tackling complex scientific and engineering challenges. The firm's strategy is centered around its highly specialized accelerator programs, which provide intensive support, mentorship, and capital to nascent companies in specific sectors.

The core of SOSV's investment approach lies in its flagship programs: HAX, focusing on hard tech and industrial innovation, and IndieBio, dedicated to life sciences and biotech. Through these accelerators, SOSV typically provides an initial investment ranging from $250,000 to $500,000 in exchange for equity, coupled with hands-on operational support and access to state-of-the-art lab and workshop facilities. This structured, program-driven investment model allows SOSV to de-risk early-stage deep tech ventures and prepare them for subsequent funding rounds. Their commitment extends beyond the initial cheque, as they actively participate in follow-on rounds for their most promising portfolio companies.

Since its inception, SOSV has built an extensive portfolio, having invested in over 1,000 companies across various deep tech domains, including climate tech, food tech, and advanced manufacturing. This vast network and strategic follow-on support have enabled their portfolio companies to collectively raise over $11 billion in additional capital from external investors. SOSV's distinctive model, combining early-stage capital with intensive operational mentorship, positions it as a critical partner for founders building breakthrough technologies with significant global impact.

Investor Profile

SOSV has backed more than 2,703 startups, with 121 new investments in the last 12 months alone. The firm has led 1,063 rounds, about 39% of its total and boasts 76 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Convertible Note, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United States, China, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Software.
  • Led 37 rounds in the past year.
  • Typical check size: $250K – $1M.

Stage Focus

  • Seed (50%)
  • Convertible Note (23%)
  • Pre Seed (13%)
  • Series A (6%)
  • Series Unknown (4%)
  • Series B (2%)
  • Series C (1%)
  • Angel (1%)

Country Focus

  • United States (49%)
  • China (7%)
  • United Kingdom (6%)
  • Canada (6%)
  • Ireland (4%)
  • India (3%)
  • Singapore (3%)
  • Hong Kong (2%)
  • Germany (2%)
  • France (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Food And Beverage
  • Artificial Intelligence (Ai)
  • Medical
  • Information Technology
  • Manufacturing
  • Hardware
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SOSV frequently co-invest with?

HAX
North America, California, United States, San Francisco
Co-Investments: 572
HAX Boost
North America, California, United States, San Francisco
Co-Investments: 32
500 Global
North America, California, United States, San Francisco
Co-Investments: 22
Food-X
North America, New York, United States, New York
Co-Investments: 133
dlab
North America, New York, United States, New York
Co-Investments: 25
Enterprise Ireland
Europe, Dublin, Ireland, Dublin
Co-Investments: 19
IndieBio
North America, California, United States, San Francisco
Co-Investments: 519
RebelBio
Europe, England, United Kingdom, London
Co-Investments: 126
Entrepreneur First
Europe, England, United Kingdom, London
Co-Investments: 24
Artesian VC
Oceania, Victoria, Australia, Melbourne
Co-Investments: 56

Which angels does SOSV often collaborate with?

JD
North America, California, United States, Menlo Park
Shared Deals: 3
SV
North America, New Hampshire, United States, Salem
Shared Deals: 2
CD
North America, California, United States, San Francisco
Shared Deals: 3
George Godula
Asia, Shanghai, China, Shanghai
Shared Deals: 3
WH
North America, Massachusetts, United States, Boston
Shared Deals: 6
BG
North America, Washington, United States, Seattle
Shared Deals: 4
ED
North America, New York, United States, New York
Shared Deals: 3
UG
North America, California, United States, San Francisco
Shared Deals: 3
GC
North America, California, United States, Los Angeles
Shared Deals: 3
KM
North America, Colorado, United States, Denver
Shared Deals: 4

What are some of recent deals done by SOSV?

TippingPoint Biosciences

San Francisco, California, United States

TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.

Biotechnology
SeedMar 31, 2026
Amount Raised: $4,500,000
Flair

Berkeley, California, United States

Flair makes smart vents and wireless thermostats and advanced software for residential heating and cooling.

Energy ManagementEnergy StorageInternet of Things
Series BMar 31, 2026
Fermeate

San Francisco, California, United States

Fermeate provides photomolecular fermentation technology to increase sustainability and efficiency in the biomanufacturing industry.

BiotechnologyIndustrial ManufacturingSustainability
SeedMar 30, 2026
heXem bio

Los Angeles, California, United States

heXem bio specializes in recording solutions for the early development of humans for longevity.

Life Science
SeedMar 28, 2026
Amount Raised: $10,400,000
Cauldron Ferm

Orange, New South Wales, Australia

Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities.

Biotechnology
Series AMar 24, 2026
Amount Raised: $13,250,000
Rybodyn

San Diego, California, United States

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

BiotechnologyMedicalPharmaceuticalTherapeutics
SeedMar 24, 2026
Amount Raised: $10,000,000
Cocoon

London, England, United Kingdom

Cocoon provides environmental consulting services to businesses and develops solutions to analyze and eradicate industrial waste.

Carbon CaptureConsultingEnvironmental ConsultingSustainabilityWaste Management
Series AMar 18, 2026
Amount Raised: $15,000,000
Surf Therapeutics

Austin, Texas, United States

Surf Therapeutics is a clinical-stage firm leading the development of non-invasive ultrasound neuromodulation technology.

Health CareMedical
SeedMar 17, 2026
Amount Raised: $6,000,000
SEQUENTIAL

London, England, United Kingdom

The Skin Microbiome Testing Co.

BeautyHealth CareHealth Diagnostics
SeedMar 17, 2026
Amount Raised: $3,500,000
VALANX Biotech

Graz, Steiermark, Austria

VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.

BiotechnologyHealth CareMedicalPharmaceutical
Series UnknownMar 12, 2026
Amount Raised: $3,466,513

Find More Investors Like SOSV

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

SOSV | Pipeseed